Testing New Method of Analyzing MR Images
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00630318|
Recruitment Status : Terminated (Unable to accrue enough subjects to analyze data.)
First Posted : March 7, 2008
Last Update Posted : January 12, 2017
|Condition or disease||Intervention/treatment||Phase|
|Breast Abnormalities||Device: MRI||Phase 1|
The purpose of this study is to develop and evaluate new MR imaging techniques and protocols for non-invasive monitoring of anti-angiogenesis treatment of breast cancer. This feasibility study is a preliminary imaging study to test this imaging protocol on subjects already undergoing MR for clinical purposes.
The specific objective of this research study is to develop and validate both MRI and functional MRI data acquisition methods, task paradigms, and post-processing techniques to ensure reliability of results.
The information derived from this research is intended to be applied to a future study of subjects undergoing experimental anti-angiogenesis drug therapy.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||12 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Imaging Protocol Design for Anti-Angiogenesis Tracking With MRI|
|Study Start Date :||March 2008|
|Actual Primary Completion Date :||July 2010|
|Actual Study Completion Date :||July 2010|
- To provide preliminary data for a larger study that this type of imaging can be used to monitor the effectiveness of anti-angiogenic therapy. [ Time Frame: After analysis of images ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00630318
|United States, Indiana|
|Indianapolis, Indiana, United States, 46202|
|Principal Investigator:||Susan E. Clare, MD, Ph.D.||Indiana University|